MID-VOLUME · FEMALE-LED
progesterone Side Effects
progesterone (also sold as Prometrium) sits MID-VOLUME #229 of 524 by FAERS report count. Lead signal: FEMALE-LED - 97% of sex-coded reports are female (18,521 F / 608 M). Demographics and serious-outcome tables follow.
Data updated 2026-05-15
- 21,004
- FAERS reports
FDA Adverse Event Reporting System extract for progesterone. Stamp set WATCHLIST · DEATH-MARKED · HOSP-MID. How figures are compiled.
progesterone reporting skew - 97% of sex-coded reports are female (18,521 F / 608 M). Volume band MID-VOLUME #229 of 524 by FAERS report count; caseload WATCHLIST.
Mid-book FAERS page for progesterone (Prometrium) (21,004 reports). Signature FEMALE-LED. Dominant age band on file: 45-64. Educational reference only.
Counts from the openFDA FAERS extract (2004–2025). Stamps WATCHLIST · DEATH-MARKED · HOSP-MID · FEMALE-LED.
HEADACHE leads 1,946 of 21,004 reports
FEMALE-LED reporters · age peak 45-64
Female-led reporters (97% of sex-coded rows)
Age peak 45-64 (6,819 reports)
FAERS filings rising toward 2025
Reactions in Death Reports
Death appears on 476 reports (2.3% - MARKED). Reactions below co-occur in those rows only.
| Reaction | Reports |
|---|---|
| FOETAL DEATH | 129 |
| THROMBOCYTOPENIA | 129 |
| PYREXIA | 126 |
| HEADACHE | 125 |
| PAIN | 125 |
| PSORIASIS | 121 |
| FATIGUE | 120 |
| HYPERTENSION | 120 |
| PRESCRIBED OVERDOSE | 118 |
| RHEUMATOID ARTHRITIS | 118 |
| TEMPERATURE REGULATION DISORDER | 118 |
| UPPER RESPIRATORY TRACT INFECTION | 118 |
| FLUID RETENTION | 117 |
| HEPATIC ENZYME INCREASED | 116 |
| JOINT SWELLING | 116 |
| CONTRAINDICATED PRODUCT ADMINISTERED | 115 |
Reactions in Hospitalization Reports
Hospitalization mid-share (3,394, 16.2%). Co-reported reactions:
| Reaction | Reports |
|---|---|
| OVARIAN HYPERSTIMULATION SYNDROME | 266 |
| DYSPNOEA | 250 |
| FATIGUE | 241 |
| HEADACHE | 236 |
| NAUSEA | 234 |
| PAIN | 205 |
| VOMITING | 186 |
| DIARRHOEA | 173 |
| DIZZINESS | 166 |
| PYREXIA | 162 |
| MATERNAL EXPOSURE DURING PREGNANCY | 156 |
| FALL | 146 |
| ABDOMINAL PAIN | 136 |
| ANXIETY | 135 |
| ARTHRALGIA | 132 |
| ASTHENIA | 128 |
| PNEUMONIA | 120 |
| FOETAL EXPOSURE DURING PREGNANCY | 117 |
How to read progesterone FAERS figures (WATCHLIST · DEATH-MARKED · HOSP-MID)
FAERS holds 21,004 voluntary reports linked to progesterone (Prometrium), 2004-2025. Death is listed on 476 (2.3%). Hospitalization appears on 3,394 (16.2%). Top co-reported indication: Product Used For Unknown Indication.
Mid-volume extract - treat DEATH-MARKED · HOSP-MID as signal-detection rates next to 97% of sex-coded reports are female (18,521 F / 608 M).
Read with progesterone
Peers ranked by ABS(total_reports), then an ABS(death_share) pole; guide hop follows DEATH-MARKED · HOSP-MID stamps.
ABS(total_reports) peer at 20,856 FAERS cases (Δ 148 lighter vs progesterone); DEATH-HEAVY · HOSP-MID · FEMALE-LED vs this page's WATCHLIST · DEATH-MARKED · HOSP-MID · FEMALE-LED.
ABS(total_reports) peer at 21,191 FAERS cases (Δ 187 heavier vs progesterone); DEATH-HEAVY · HOSP-MID · FEMALE-LED vs this page's WATCHLIST · DEATH-MARKED · HOSP-MID · FEMALE-LED.
ABS(total_reports) peer at 20,677 FAERS cases (Δ 327 lighter vs progesterone); DEATH-HEAVY · HOSP-HEAVY · MALE-LED vs this page's WATCHLIST · DEATH-MARKED · HOSP-MID · FEMALE-LED.
ABS(total_reports) peer at 21,352 FAERS cases (Δ 348 heavier vs progesterone); DEATH-HEAVY · HOSP-HEAVY · SEX-BALANCED vs this page's WATCHLIST · DEATH-MARKED · HOSP-MID · FEMALE-LED.
ABS(death_share) pole at 62.1% death-mentioned reports (Δ 59.8 pp vs progesterone's DEATH-MARKED): CASELOAD · HOSP-MID.
progesterone stamps WATCHLIST · FEMALE-LED; class peers and methodology beat restating the same FAERS caveats on every effects URL.